Yanni Lin
Impact in
-
- CRISPR and Genetic Engineering
Papers in
-
- Cancer, Lipids, and Metabolism 2
-
- Autophagy in Disease and Therapy 3
- Co-authors
- Thomas James Cradick (4 shared papers)Eli J. Fine (3 shared papers)Gang Bao (3 shared papers)Zhilan Zheng (1 shared paper)Matthew Hebden Porteus (1 shared paper)Richard A. Voit (1 shared paper)Gang Bao (1 shared paper)Sheng Tong (1 shared paper)
- Journals
- Nature Chemical Biology (2 papers)Nucleic Acids Research (2 papers)Nature Communications (1 paper)New Phytologist (1 paper)Algal Research (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Yanni Lin
12 papers receiving 279 citations
Peers
Comparison fields: 5 of 51
- Drug Discovery 1
- Molecular Biology 161
- Cancer Research 17
- Immunology 20
- Oncology 19
Countries citing papers authored by Yanni Lin
This map shows the geographic impact of Yanni Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanni Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanni Lin more than expected).
Fields of papers citing papers by Yanni Lin
This network shows the impact of papers produced by Yanni Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanni Lin. The network helps show where Yanni Lin may publish in the future.
Co-authors
The 21 scholars most cited alongside Yanni Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 114 | |
| 2 | 2014 | 45 | |
| 3 | 2025 | 28 | |
| 4 | 2013 | 24 | |
| 5 | 2021 | 17 | |
| 6 | 2025 | 15 | |
| 7 | 2025 | 12 | |
| 8 | 2025 | 9 | |
| 9 | 2025 | 8 | |
| 10 | 2014 | 6 | |
| 11 | 2020 | 6 | |
| 12 | 2023 | 5 | |
| 13 | 2026 | 0 |
About Yanni Lin
Yanni Lin is a scholar working on Cancer Research, Epidemiology, Immunology, Molecular Biology and Biomaterials, having authored 13 papers that have together received 289 indexed citations. Recurring topics across this work include Autophagy in Disease and Therapy (3 papers), CRISPR and Genetic Engineering (3 papers), Cancer, Lipids, and Metabolism (2 papers), interferon and immune responses (2 papers), Plant Molecular Biology Research (1 paper), Photosynthetic Processes and Mechanisms (1 paper), Algal biology and biofuel production (1 paper) and Nanoparticle-Based Drug Delivery (1 paper). The work is most often cited by research in Drug Discovery (1 citation), Molecular Biology (161 citations), Cancer Research (17 citations), Immunology (20 citations) and Oncology (19 citations). Yanni Lin has collaborated with scholars based in China and United States. Frequent co-authors include Thomas James Cradick, Eli J. Fine, Gang Bao, Zhilan Zheng, Matthew Hebden Porteus, Richard A. Voit, Gang Bao, Sheng Tong, Yinchu Wang and Song Qin. Their work appears in journals such as Nature Chemical Biology, Nucleic Acids Research, Nature Communications, New Phytologist and Algal Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.